Sponsor pipeline

Albireo, an Ipsen Company clinical trial pipeline

Get alerts when Albireo, an Ipsen Company's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05035030 Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome Alagille Syndrome Active, Not Recruiting 2026-10-02
NCT05426733 An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in… Biliary Atresia Active, Not Recruiting 2026-10-01
Get alerts when Albireo, an Ipsen Company's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free